Sara Colombetti

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

Roberta Palumbo, Maurilio Sampaolesi, Francesco De Marchis et al. · The Journal of Cell Biology · 2004 · 465 citations · Full text

Life Sciences, Cell Biology, Cell Signaling +13

Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapy

Maud Mayoux, Andreas Roller, Vesna Pulko et al. · Science Translational Medicine · 2020 · 380 citations

Life Sciences, Immunology, Oncology +17

A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors

Marina Bacac, Tanja Fauti, Johannes Sam et al. · Clinical Cancer Research · 2016 · 355 citations · Full text

Pharmacy, Immunology, Oncology +17

PD-1-cis IL-2R agonism yields better effectors from stem-like CD8+ T cells

Laura Codarri Deak, Valeria Nicolini, Masao Hashimoto et al. · Nature · 2022 · 268 citations · Full text

Life Sciences, Cancer Biology, Immunology +16

Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy

Christina Claus, Claudia Ferrara, Wei Xu et al. · Science Translational Medicine · 2019 · 266 citations · Full text

Medicine, Immunology, Oncology +17